Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02208895
Other study ID # 3785
Secondary ID VAMC OKC
Status Completed
Phase
First received
Last updated
Start date February 2014
Est. completion date August 28, 2019

Study information

Verified date March 2020
Source University of Oklahoma
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pleural fluid glucose levels measured with bed-side point of care methods such as finger stick glucometers and I-STAT device correlate with the traditional in-lab testing methods.


Description:

This is a prospective study which will identify patients in VAMC with a diagnosis of pleural effusion and undergoing diagnostic thoracentesis.The investigators plan to analyze the two bedside point-of-care fluid glucose testing methods (I- STAT device and finger stick glucometer) to measure pleural fluid glucose levels. The results obtained from these two methods will be compared to the traditionally in lab measured pleural fluid glucose levels.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date August 28, 2019
Est. primary completion date August 28, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- any patient 18 to 99 year old with a diagnosis of pleural effusion and undergoing a diagnostic thoracentesis.

Exclusion Criteria:

- Inability to provide informed consent by the patient or the surrogate to enroll for the planned study.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States VAMC OKC Oklahoma City Oklahoma

Sponsors (1)

Lead Sponsor Collaborator
University of Oklahoma

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation of pleural fluid glucose measured with a glucometer and the I-STAT with the pleural fluid glucose level measured in the Lab Primary outcome will be the inter-assay precision of the finger stick glucometer and the I-STAT device as compared to the Gold standard in lab testing of pleural glucose.This will be done using the Bland-Altman plot. <1 hour
Secondary Intra assay precision of pleural fluid glucose measured with a glucometer and with an I-STAT device. assessment of intra assay precision of of 2 measurements of pleural fluid glucose done by the glucometer as well as the ISTAT device . < 1hour
See also
  Status Clinical Trial Phase
Completed NCT01374542 - Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Completed NCT00005906 - Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Phase 2